Bacteriocin DNA nanocomplexes as immunotherapeutic carriers

dc.citation.epage137en_US
dc.citation.spage136en_US
dc.contributor.authorYağcı, Fuat Cemen_US
dc.contributor.authorGüçlüler, Gözdeen_US
dc.contributor.authorKıran, F.en_US
dc.contributor.authorGürsel, İhsanen_US
dc.coverage.spatialMainz, Germanyen_US
dc.date.accessioned2019-07-08T06:31:44Z
dc.date.available2019-07-08T06:31:44Z
dc.date.issued2012-05en_US
dc.departmentDepartment of Molecular Biology and Geneticsen_US
dc.descriptionConference Name: 10th CIMT Annual Meeting, Towards Next-Generation Cancer Immunotherapy, 2012en_US
dc.descriptionDate of Conference: 23-25 May 2012en_US
dc.description.abstractSynthetic oligodeoxynucleotides (CpG-ODNs) and bacterial DNA containing unmethylated CpG dinucleotides (CpG motifs) are clinical candidates as anti-cancer agents, immune adjuvants, anti-allergens, and stand alone immunoprotective agents. Two different classes of CpG-ODNs were identified for clinical applications. B-Class ODNs, also known as K-type CpG ODN, have phosphorothioate backbones and potent B- cell activators. A-Class ODNs (or D-type ODNs) have mixed backbone and flanking G-runs at their 3`and 5-ends.en_US
dc.identifier.urihttp://hdl.handle.net/11693/52144
dc.language.isoEnglishen_US
dc.publisherAssociation for Cancer Immunotherapyen_US
dc.source.titleAbstract Book 2012, 10th CIMT Annual Meetingen_US
dc.titleBacteriocin DNA nanocomplexes as immunotherapeutic carriersen_US
dc.typeConference Paperen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Bacteriocin_DNA_nanocomplexes_as_immunotherapeutic_carriers.pdf
Size:
179.78 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: